Furthermore, in conditions of endothelial dysfunction, NO bioavailability is often reduced in relation to increased expression of VCAM‐1 and ICAM‐1 through enhanced reactive oxidative stress in the vessel walls (Wright et al., 2015). The gene discussed is ICAM1; the disease is endothelial dysfunction.